Perceptive Advisors’s Ambrx Biopharma Inc AMAM Stock Holding History

Perceptive Advisors’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-78,811	Closed	-$1.12M	–	128
2023 Q4	$1.12M	Buy	+78,811	New	+$896K	0.03%	92

Perceptive Advisors's AMAM Position: Q1 2024 in Review

Perceptive Advisors sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 78,811 shares — an estimated $1.12M sold.

Perceptive Advisors first reported a position in AMAM in Q4 2023 and held it in 1 quarter. The position peaked at $1.12M in Q4 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

Perceptive Advisors reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
Perceptive Advisors sold 78,811 Ambrx Biopharma Inc shares in Q1 2024, an estimated $1.12M.
Perceptive Advisors first reported a position in Ambrx Biopharma Inc in Q4 2023 and held it in 1 quarter.
Perceptive Advisors's Ambrx Biopharma Inc position peaked at $1.12M in Q4 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on Perceptive Advisors's 13F filing for Q1 2024, filed 15 May 2024.